"I think that, across industries, AI is going to provide a great benefit to our day-to-day practice," says Michael Karellas, MD.
In this video, Michael Karellas, MD, discusses the potential uses of artificial intelligence in urologic cancers. Karellas is an assistant professor of urology at Yale School of Medicine a member of Yale Cancer Center in New Haven, Connecticut.
In general, technology is improving our day-to-day practice overall. I think that, across industries, AI is going to provide a great benefit to our day-to-day practice. But in the oncology world, the way it's helping us primarily right now is in the data research and some of the algorithms behind the scenes. But in day-to-day practice, we're not quite there yet, as far as having AI dictate your cancer care. As an extension of that, most of the cancers that we treat have guidelines that are established by national bodies that are evidence based. From that aspect, we rely on AI heavily or just database management in general, but the way the guidelines are structured, and for most cancers, there's a nuanced approach and an individualized approach for patients with their cancer care. Our challenge over the years has been to try to integrate the data with the patient care, and I think AI will help us with that, but we're not quite there yet in a day-to-day practice modality.
This transcription was edited for clarity.
Medicare’s G2211 and thoughts on how to best use it in urology
May 1st 2024"We felt that it was important to again address this topic because we have received numerous questions regarding the correct use of this code and we have had some experience using the code now that it is active and been able to observe some of the initial payment processing by the payer," write Jonathan Rubenstein, MD, and Mark Painter.
Experts develop guide on online tools to reduce costs of urologic drugs
April 22nd 2024"At a time when patients are increasingly concerned about prescription drugs, this information will provide a useful starting point for making essential medications as affordable as possible," says Ruchika Talwar, MD.